US 12,275,728 B2
O-glycoprotein-2-acetamido-2-deoxy-3-D-glucopyranosidase inhibitors
Nathan Genung, Charlestown, MA (US); Kevin M. Guckian, Northborough, MA (US); Jeffrey Vessels, Marlborough, MA (US); Lei Zhang, Westford, MA (US); Ryan Gianatassio, Everett, MA (US); Edward Yin Shiang Lin, Ashland, MA (US); and Zhili Xin, Cambridge, MA (US)
Assigned to BIOGEN MA INC., Cambridge, MA (US)
Filed by BIOGEN MA INC., Cambridge, MA (US)
Filed on May 24, 2024, as Appl. No. 18/673,619.
Application 18/673,619 is a continuation of application No. 17/276,502, previously published as PCT/US2019/051661, filed on Sep. 18, 2019.
Claims priority of provisional application 62/750,000, filed on Oct. 24, 2018.
Claims priority of provisional application 62/733,484, filed on Sep. 19, 2018.
Prior Publication US 2024/0308995 A1, Sep. 19, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 417/14 (2006.01); A61P 25/28 (2006.01); C07D 417/06 (2006.01)
CPC C07D 417/14 (2013.01) [A61P 25/28 (2018.01); C07D 417/06 (2013.01)] 2 Claims
 
1. A compound represented by the following structural formula:

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.